What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Surgery
- Stroke
Alastair M. Buchan mostly deals with Stroke, Ischemia, Anesthesia, Internal medicine and Neuroprotection.
His Stroke research includes elements of Surgery, Prospective cohort study, Central nervous system disease and Tissue plasminogen activator.
Alastair M. Buchan combines subjects such as Antagonist, AMPA receptor, NBQX, Hippocampal formation and Vascular disease with his study of Ischemia.
He has included themes like Glutamate receptor, Occlusion and Infarction in his Anesthesia study.
His work investigates the relationship between Internal medicine and topics such as Cardiology that intersect with problems in Logistic regression.
His Neuroprotection research is multidisciplinary, incorporating elements of Ischemic cascade and Intensive care medicine.
His most cited work include:
- Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (4170 citations)
- Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy (1475 citations)
- Glial and neuronal control of brain blood flow. (1469 citations)
What are the main themes of his work throughout his whole career to date?
Alastair M. Buchan mainly focuses on Stroke, Ischemia, Internal medicine, Neuroprotection and Cardiology.
His Stroke research is multidisciplinary, relying on both Physical therapy, Surgery, Tissue plasminogen activator and Intensive care medicine.
The Ischemia study combines topics in areas such as Hypothermia, Anesthesia, Central nervous system disease, Neuroscience and Pathology.
In his study, Cerebral infarction is strongly linked to Infarction, which falls under the umbrella field of Anesthesia.
His Internal medicine study frequently draws connections between adjacent fields such as Endocrinology.
His Neuroprotection research incorporates elements of Excitotoxicity and Glutamate receptor.
He most often published in these fields:
- Stroke (40.81%)
- Ischemia (29.83%)
- Internal medicine (25.54%)
What were the highlights of his more recent work (between 2012-2021)?
- Stroke (40.81%)
- Internal medicine (25.54%)
- Thrombolysis (13.84%)
In recent papers he was focusing on the following fields of study:
Alastair M. Buchan focuses on Stroke, Internal medicine, Thrombolysis, Neuroprotection and Cardiology.
He interconnects Infarction, Cerebral blood flow and Intensive care medicine in the investigation of issues within Stroke.
His Internal medicine research focuses on Endocrinology and how it connects with Neurotoxicity.
Alastair M. Buchan has researched Thrombolysis in several fields, including Clinical trial, Surgery, Multimodal therapy, Fibrinolytic agent and Tissue plasminogen activator.
His Neuroprotection research includes themes of Endogeny, Ischemia and Mechanism.
His studies examine the connections between Ischemia and genetics, as well as such issues in PI3K/AKT/mTOR pathway, with regards to Autophagy.
Between 2012 and 2021, his most popular works were:
- Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (4170 citations)
- Capillary pericytes regulate cerebral blood flow in health and disease (888 citations)
- Tsc1 (hamartin) confers neuroprotection against ischemia by inducing autophagy. (146 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Surgery
- Stroke
The scientist’s investigation covers issues in Stroke, Thrombolysis, Cell biology, Intensive care medicine and Neuroprotection.
His Stroke research incorporates themes from Anesthesia and Cardiology.
His Thrombolysis research includes elements of Malignancy, Clinical trial and Surgery, Multimodal therapy.
The concepts of his Cell biology study are interwoven with issues in Vasoconstriction, Pericyte and Vasodilation.
His work deals with themes such as Alternative medicine and Physical therapy, which intersect with Intensive care medicine.
As a part of the same scientific family, Alastair M. Buchan mostly works in the field of Pharmacology, focusing on mTORC1 and, on occasion, Programmed cell death and Autophagy.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
